Astec Lifesciences
- Advice
- Hold
Astec Lifesciences Performance
Day Range
- Low 1305
- High 1366
52 Week Range
- Low 1045
- High 2288.8
- Open Price1330
- Previous Close1324.4
- Volume12857
Start SIP in Astec Lifesciences
Start SIPAstec Lifesciences Investment Rating
-
Master Rating:
-
Astec Lifesciences has an operating revenue of Rs. 586.75 Cr. on a trailing 12-month basis. An annual revenue de-growth of -7% needs improvement, Pre-tax margin of 6% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 18 which is a POOR score indicating inconsistency in earnings, a RS Rating of 13 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 139 indicates it belongs to a poor industry group of Chemicals-Agricultural and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 143 | 127 | 117 | 200 | 184 | 272 |
Operating Expenses Qtr Cr | 140 | 122 | 105 | 166 | 159 | 207 |
Operating Profit Qtr Cr | 3 | 5 | 12 | 33 | 25 | 65 |
Depreciation Qtr Cr | 9 | 8 | 9 | 8 | 9 | 11 |
Interest Qtr Cr | 6 | 6 | 6 | 5 | 4 | 3 |
Tax Qtr Cr | -3 | -1 | 0 | 6 | 4 | 15 |
Net Profit Qtr Cr | -8 | -5 | 1 | 18 | 11 | 43 |
Astec Lifesciences Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 1
- Bearish Moving Average
- ___
- 15
- 20 Day
- ₹1367.05
- 50 Day
- ₹1356.05
- 100 Day
- ₹1372.06
- 200 Day
- ₹1447.21
- 20 Day
- ₹1383.56
- 50 Day
- ₹1333.93
- 100 Day
- ₹1359.97
- 200 Day
- ₹1429.91
Astec Lifesciences Resistance and Support
Resistance | |
---|---|
First Resistance | ₹1370.4 |
Second Resistance | ₹1398.7 |
Third Resistance | ₹1431.4 |
RSI | 45.44 |
MFI | 32.73 |
MACD Single Line | 12.01 |
MACD | 1.35 |
Support | |
---|---|
First Resistance | ₹1309.41 |
Second Resistance | ₹1276.7 |
Third Resistance | ₹1248.41 |
Astec Lifesciences Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 13,931 | 736,393 | 52.86 |
Week | 9,052 | 496,154 | 54.81 |
1 Month | 17,279 | 877,783 | 50.8 |
6 Month | 42,883 | 1,404,847 | 32.76 |
Astec Lifesciences Result Highlights
Astec Lifesciences Synopsis
NSE-Chemicals-Agricultural
Astec Lifesciences L is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company’s Total Operating Revenue is Rs. 628.17 Cr. and Equity Capital is Rs. 19.61 Cr. for the Year ended 31/03/2023. Astec Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/1994 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1994PLC076236 and registration number is 076236.Market Cap | 2,632 |
Sales | 587 |
Shares in Float | 0.65 |
No of funds | 35 |
Yield | 0.11 |
Book Value | 6.27 |
U/D Vol ratio | 2.1 |
LTDebt / Equity | 3 |
Alpha | -0.16 |
Beta | 0.77 |
Astec Lifesciences
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 66.76% | 66.77% | 66.77% | 66.77% |
Mutual Funds | 9.14% | 9.57% | 8.45% | 8.71% |
Foreign Portfolio Investors | 1.95% | 2.29% | 2.19% | 1.53% |
Financial Institutions/ Banks | ||||
Individual Investors | 17.75% | 16.81% | 17.86% | 18.02% |
Others | 4.4% | 4.56% | 4.73% | 4.97% |
Astec Lifesciences Management
Name | Designation |
---|---|
Mr. Nadir B Godrej | Chairman |
Mr. Ashok V Hiremath | Non Executive Director |
Mr. Balram Singh Yadav | Non Executive Director |
Mr. Anurag Roy | WholeTime Director & CEO |
Dr. Brahma Nand Vyas | Independent Director |
Mr. Vijay Kashinath Khot | Independent Director |
Mr. R R Govindan | Independent Director |
Mr. Nandkumar Dhekne | Independent Director |
Ms. Anjali Gupte | Independent Director |
Mr. Burjis Nadir Godrej | Non Executive Director |
Astec Lifesciences Forecast
Price Estimates
Astec Lifesciences Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-07-27 | Quarterly Results | |
2023-05-02 | Audited Results & Final Dividend | |
2023-01-30 | Quarterly Results & Others | Inter alia, the Board may also consider and approve issuance of Debentures or debt securities upto such limit as may be deemed appropriate and approved by the Board. per share(15%)Final Dividend |
2022-10-28 | Quarterly Results | |
2022-07-25 | Quarterly Results |
- Company Name
- CMP
- Chg(%)
- IndusInd Bank
- 1453
- 2.9
- Maruti Suzuki
- 10535
- 2.4
- St Bk of India
- 598
- 1.7
- M & M
- 1607
- 1.5
- Bajaj Finserv
- 1544
- 1.1
- Company Name
- CMP
- Chg(%)
Astec Lifesciences FAQs
What is Share Price of Astec Lifesciences ?
Astec Lifesciences share price is ₹1342 As on 23 September, 2023 | 00:40
What is the Market Cap of Astec Lifesciences ?
The Market Cap of Astec Lifesciences is ₹2631.8 Cr As on 23 September, 2023 | 00:40
What is the P/E ratio of Astec Lifesciences ?
The P/E ratio of Astec Lifesciences is 440.8 As on 23 September, 2023 | 00:40
What is the PB ratio of Astec Lifesciences ?
The PB ratio of Astec Lifesciences is 6.3 As on 23 September, 2023 | 00:40